MIRAPEX For Patients and Caregivers

Diagnosing RLS

Type sizer AA

RLS is a common yet underdiagnosed condition.10 As a result, several tools have been developed for its diagnosis and evaluation.

Diagnosis

In 1995, a group of experts in the field of RLS formed the International RLS Study Group (IRLSSG) and established 4 essential criteria for RLS diagnosis.12 In 2003, these criteria were updated by the IRLSSG in conjunction with the National Institutes of Health to reflect the existing state of RLS research. These 4 essential criteria are used as the defining characteristics of RLS. When combined with a physical examination and a thorough patient history, an initial diagnosis can be made by adapting diagnostic questions around the essential criteria.11,12

Essential Criteria for RLS Diagnosis11,12

Learn more about clinical evaluation when making a diagnosis of Restless Legs Syndrome (RLS)

Learn more about clinical evaluation when making a diagnosis of Restless Legs Syndrome (RLS)

Learn more about clinical evaluation when making a diagnosis of Restless Legs Syndrome (RLS)

Discover the proven efficacy of MIRAPEX.

Discover the proven efficacy of MIRAPEX. Learn more<.a>

Discover the proven efficacy of MIRAPEX.

IMPORTANT SAFETY INFORMATION ABOUT MIRAPEX: MIRAPEX tablets are indicated for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS).

MIRAPEX may cause patients to fall asleep without any warning, even while doing normal daily activities, such as driving. When taking MIRAPEX, hallucinations may occur and sometimes patients may feel dizzy, sweaty or nauseated upon standing up. The most common side effects in clinical trials for RLS were nausea, headache, and tiredness. Patients should talk with their doctor if they experience these problems.

Patients and caregivers should be informed that impulse control disorders/compulsive behaviors may occur while taking medicines, including pramipexole, to treat Parkinson's disease and RLS.

This information is intended for U.S. residents only. Products discussed herein may have different labeling in different countries.

Please see full Prescribing Information, including patient information.

If you can't afford your MIRAPEX, our patient assistance program may be able to help. Call 1-800-556-8317

If you can't afford your MIRAPEX, our patient assistance program may be able to help. Call 1-800-556-8317